Skip to Main Content

Author Archives: Mara Pillinger

06.17.20

Are Immunity Certificates Fool’s Gold?

By Mara Pillinger

The COVID-19 pandemic is far from over, but lockdowns are unsustainable. Policymakers are desperately searching for new policy tools that will allow economies to get back up and running while diminishing the risk to the vast majority of the population still vulnerable to coronavirus. One solution being discussed in the US, the UK, Germany, Chile, […]

Categories:
Tags:
Thematic Areas:

05.08.20

Lessons from the HIV Policy Lab: tracking national HIV policies and ART access amidst COVID-19

By Mara Pillinger

This post was authored by Kate Daley (with Mara Pillinger)   COVID-19 presents a unique opportunity to accelerate and expand national policies on differentiated service delivery (DSD) for people living with HIV (PLHIV). DSD is “a responsive, client-centred approach that simplifies and adapts HIV services across the cascade to better serve individual needs and reduce […]

Categories:

02.15.20

Pandemics Do Have Borders

By Mara Pillinger

One of the most common refrains in global health security is that pandemics don’t respect national borders. But the COVID-19 epidemic has turned up the heat under simmering disputes over Taiwan’s and Hong Kong’s status vis-à-vis the People’s Republic of China, reminding us that politics of sovereignty and autonomy don’t stop for pandemics, either. The […]

Tags:

01.27.20

Politics & PHEIC Declarations

By Mara Pillinger

On Thursday, after delaying for an extra day of deliberation, the World Health Organization (WHO) decided not to declare the outbreak of pneumonia caused by a new coronavirus, 2019-nCov, a public health emergency of international concern (PHEIC). The International Health Regulations (2005) define a PHEIC as “an extraordinary event that poses a public health risk […]

Categories:
Tags:
Thematic Areas:

12.19.19

Byanyima’s Strategy: Focus on Injustice & Innovation in the Fight Against HIV

By Mara Pillinger

Last week, UNAIDS new Executive Director, Dr. Winnie Byanyima, announced the creation of a strategic advisory group to be co-chaired by Georgetown’s own Matt Kavanagh (along with Quarraisha Abdool Karim, Associate Scientific Director at CAPRISA, and Rico Gustav, Executive Director GNP+). Since you’re reading a policy research institute’s blog, you probably don’t need convincing that […]

Tags:

11.14.19

The Challenges of Turning Policies Into Data

By Mara Pillinger

If you’re reading this blog, you’re probably more than familiar with evidence-based policymaking. You may not be as used to thinking about laws and policies themselves as a form of data. But they can be. By collecting, mapping and analyzing laws/policies across jurisdictions and over time, we can systematically evaluate the relationships between policies and […]

Tags:

10.18.19

More or the same? Reflecting on debates around the Global Fund’s mandate

By Mara Pillinger

Last week, the Global Fund met its replenishment target of $14B. The news was greeted mostly with sighs of relief, especially because it was a near thing. The Global Fund is the largest star in the global health firmament, channeling more money than any other multilateral actor.* It has leveraged this funding to impressive ends. […]

Tags:

09.27.19

Migrants’ Access to Healthcare: Data Wanted

By Mara Pillinger

Countries’ obligations to respond to the health needs of migrants (including regular and irregular migrants, refugees, and asylum-seekers) was a topic of conversation at the O’Neill Institute this week. In 2016, the UN General Assembly adopted the New York Declaration for Refugees and Migrants, which proclaims Member States’ “commit[ment] to protecting the safety, dignity and […]

Tags:

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.